Drugs Made In America Acquisition II Corp. Unit (DMIIU) Valuation Score

DMIIUDrugs Made In America Acquisition II Corp.

Shell Companies

2/18

Expensive

Share Price

$10.23

14/10/2026

Book Value

(SH Equity)

As of 30/06/2026

$495.96M

Net Debt

As of 30/06/2026

$275.03K

Free Cash Flow

As of 30/06/2026

-$1.28M

Shares Outstanding

As of 30/06/2026

63.70M

EPS (Diluted)

As of 30/06/2026

N/A

P/E Ratio

As of 14/10/2026

N/A

Mdn Growth Rate

(Net Income: 4yrs)

As of 30/06/2026

N/A

Dividend Yield

As of 14/10/2026

0.00%

Payout Ratio

As of 14/10/2026

N/A

Sign in or register for free to view the complete valuation breakdown and historical price charts, including priced in gold chart.

🔒

Disclaimer

Capital at risk. The value of investments can go down as well as up. Past performance is not indicative of future results. This tool provides balance sheet analysis and does not constitute personal financial advice. Do your own due diligence.
The score is backward-looking — it uses trailing twelve-month (TTM) data, not forward estimates.
Sector differences are not adjusted for. Capital-intensive industries (e.g. airlines and utilities) naturally carry more debt and will score lower on debt metrics.
The score does not account for management quality, competitive moats, or macro-economic conditions.
It is designed as a screening tool, not a buy/sell recommendation. Always combine with qualitative research. The User is solely responsible for the outcome of their investments.